Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

New York, January 13, 2026, 14:25 EST — Regular session

Amphenol Corp shares climbed 2.2%, hitting $148.28 in afternoon trading Tuesday, defying the broader market slump. The S&P 500 ETF SPY and the tech-focused QQQ both slipped roughly 0.4%.

The connector maker has been on the rise after finalizing its $10.5 billion acquisition of CommScope and as analysts updated their ratings on the stock. The spotlight remains on data-center and communications wiring — essentially the infrastructure behind the expansion — where even minor demand changes can swiftly alter the earnings outlook.

Amphenol announced on Monday that it has finalized its acquisition of CommScope’s Connectivity and Cable Solutions (CCS) business. CEO R. Adam Norwitt highlighted that the deal “adds significant fiber optic interconnect capabilities” for IT data communications and communications networks.

The company projects CCS will bring in roughly $4.1 billion in sales for full-year 2026 and add around $0.15 to diluted earnings per share that year, excluding acquisition-related costs. A filing revealed the purchase price was approximately $10.5 billion in cash, with post-closing adjustments yet to be finalized.

Barclays analyst Guy Hardwick bumped Amphenol to Overweight from Equal-Weight and lifted his price target to $156 from $143, Benzinga reported. In analyst speak, Overweight signals he expects the stock to beat its peers.

Barclays highlighted “strong tailwinds” from content in data center AI architectures in a note shared by TheFly, adding that the CCS deal is moving ahead of expectations. 1

Citi analyst Asiya Merchant bumped her price target to $175 from $160 while maintaining a Buy rating. She described herself as “constructive” on connector companies heading into 2026, noting stronger end demand.

Truist bumped its price target up to $182 from $180 and maintained a Buy rating, highlighting that the CommScope deal should boost sales by 17%. The firm also praised Amphenol’s acquisition history as “excellent.”

The stock rose 3.5% Monday, closing at $145.11 for its second day up in a row, with volume surpassing its 50-day average, according to MarketWatch data. 2

TE Connectivity climbed 1.2% Tuesday, providing a glimpse into overall demand for connectors and related parts.

The CCS integration marks a major shift, and Amphenol’s forward-looking statements highlight risks like employee retention and potential disruptions post-close. A slowdown in data-center spending or a rough customer and supply chain transition could put pressure on the stock after its recent surge.

Amphenol is set to release its quarterly earnings on Jan. 28 before the market opens. Investors will be focusing on early CCS contributions and the company’s outlook for demand in 2026. 3

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks
Previous Story

Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

Pony AI stock slides nearly 10% in New York trade as rate bets reset after CPI
Next Story

Pony AI stock slides nearly 10% in New York trade as rate bets reset after CPI

Go toTop